The purpose of this study is to assess the bioequivalence between Amoxicillin/Clavulanate Potassium Oral Suspension 600/42.9 mg/5 mL and Augmentin ES-600 Oral Suspension, 600/42.9 mg/5 mL in healthy, male and female subjects, under fed conditions.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Bioequivalence Based on Cmax for Amoxicillin
Timeframe: Blood samples collected over 14 hour period
Bioequivalence Based on AUC0-inf for Amoxicillin
Timeframe: Blood samples collected over 14 hour period
Bioequivalence Based on AUC0-t for Amoxicillin
Timeframe: Blood samples collected over 14 hour period
Bioequivalence Based on Cmax for Clavulanic Acid
Timeframe: Blood samples collected over 14 hour period
Bioequivalence Based on AUC0-inf for Clavulanic Acid
Timeframe: Blood samples collected over 14 hour period
Bioequivalence Based on AUC0-t for Clavulanic Acid
Timeframe: Blood samples collected over 14 hour period